Drugs Made In America Acquisition Corp. Ordinary Shares(DMAA)

Shell Companies · New York, NY

$10.90+0.01 (+0.09%)

Delayed quote: Oct 5, 2026, 1:49 PM EDT

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) EBITDA Yield: History & Chart | TGMCharts

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T12:11:21.295Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:11:21.295Z.

Quote observation: 2026-10-05T17:49:36.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -2,633,404
Quote market capitalization: 264,618,352
Total debt · period ending 2026-06-30: 950,000
Cash · period ending 2026-06-30: 20,280

FMP input reference: 015f4768d679608bc4b6bcfba81ca244afda57a14a617ca6285ea64adc9468bc

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

DMAA EBITDA Yield Metrics

EBITDA YIELD

N/A

DMAA Competitors' EBITDA Yield

DMAA

Drugs Made In America Acquisition Corp. Ordinary Shares

Current

Market Cap

$264.62M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TBCVU

Thunder Bridge Capital Partners V L

vs DMAA

Market Cap

$266.32M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CEPV

Cantor Equity Partners V, Inc. Class A Ordinary Shares

vs DMAA

Market Cap

$262.30M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AMAC

AMR Resources Acquisition Corp Class A Ordinary Shares

vs DMAA

Market Cap

$261.73M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARTC

Art Technology Acquisition Corp.

vs DMAA

Market Cap

$261.51M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GIW

GigCapital8 Corp.

vs DMAA

Market Cap

$261.19M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FACT

FACT II Acquisition Corp

vs DMAA

Market Cap

$260.97M

EBITDA Yield

N/A

TTM Avg

0.61%

3Y Avg

0.61%

5Y Avg

0.61%

CGCF

Cartesian Growth Corp. Iv

vs DMAA

Market Cap

$269.77M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FDMM

Freedom Metals Acquisition Corp.

vs DMAA

Market Cap

$270.60M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FXNC

First National Corporation

vs DMAA

Market Cap

$270.87M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)	$264.62M	N/A	N/A	N/A	N/A
Thunder Bridge Capital Partners V L (TBCVU)vs ›	$266.32M	N/A	N/A	N/A	N/A
Cantor Equity Partners V, Inc. Class A Ordinary Shares (CEPV)vs ›	$262.30M	N/A	N/A	N/A	N/A
AMR Resources Acquisition Corp Class A Ordinary Shares (AMAC)vs ›	$261.73M	N/A	N/A	N/A	N/A
Art Technology Acquisition Corp. (ARTC)vs ›	$261.51M	N/A	N/A	N/A	N/A
GigCapital8 Corp. (GIW)vs ›	$261.19M	N/A	N/A	N/A	N/A
FACT II Acquisition Corp (FACT)vs ›	$260.97M	N/A	0.61%	0.61%	0.61%
Cartesian Growth Corp. Iv (CGCF)vs ›	$269.77M	N/A	N/A	N/A	N/A
Freedom Metals Acquisition Corp. (FDMM)vs ›	$270.60M	N/A	N/A	N/A	N/A
First National Corporation (FXNC)vs ›	$270.87M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

DMAA EBITDA Yield Metrics

DMAA Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics